Su1381 EUS-Guided Gallbladder Drainage As an Alternative Treatment for Malignant Biliary Obstruction After Unsuccessful ERCP: Outcomes of Long Term Follow-Up

2011 ◽  
Vol 73 (4) ◽  
pp. AB249
Author(s):  
Masayuki Kitano ◽  
Hajime Imai ◽  
Ken Kamata ◽  
Takamitsu Komaki ◽  
Hiroki Sakamoto ◽  
...  
Endoscopy ◽  
2008 ◽  
Vol 40 (04) ◽  
pp. 340-342 ◽  
Author(s):  
K. Yamao ◽  
V. Bhatia ◽  
N. Mizuno ◽  
A. Sawaki ◽  
H. Ishikawa ◽  
...  

1999 ◽  
Vol 40 (5) ◽  
pp. 528-533 ◽  
Author(s):  
I. S. Kaskarelis ◽  
M. G. Papadaki ◽  
G. N. Papageorgiou ◽  
M. D. Limniati ◽  
N. E. Malliaraki ◽  
...  

2018 ◽  
Author(s):  
M Manno ◽  
C Barbera ◽  
VG Mirante ◽  
L Miglioli ◽  
T Gabbani ◽  
...  

2018 ◽  
Vol 87 (6) ◽  
pp. AB430
Author(s):  
Omar Ahmed ◽  
Takeshi Ogura ◽  
Hanaa Khalaf ◽  
Ehab Mohammed ◽  
Ayat Sameer ◽  
...  

2018 ◽  
Vol 24 (3) ◽  
pp. 183 ◽  
Author(s):  
Takeshi Ogura ◽  
Omar Ahmed ◽  
Ali Eldahrouty ◽  
Hanaa Khalaf ◽  
Ehab Mohammed ◽  
...  

2007 ◽  
Vol 9 (5) ◽  
pp. 424-431 ◽  
Author(s):  
Andrea M Harvey ◽  
Peter E Holt ◽  
Frances J Barr ◽  
Francesca Rizzo ◽  
Séverine Tasker

A 2-year-old female neutered Somali cat was presented with vomiting and acute onset jaundice 1 year after diagnosis of pyruvate kinase (PK) deficiency. Diagnostic investigations revealed a moderate regenerative haemolytic anaemia, severe hyperbilirubinaemia and elevated liver enzymes. Ultrasonography revealed marked distension of the gall bladder and common bile duct (CBD), consistent with extrahepatic biliary obstruction (EHBO). At cholecystotomy, the gall bladder contained purulent material, and two obstructive choleliths were removed from the CBD by choledochotomy. The cat recovered from surgery uneventfully, and serum liver enzymes and bilirubin normalised within 10 days. Postoperative treatment consisted of cephalexin, metronidazole and ursodeoxycholic acid (UDCA). Bacterial culture of the gall bladder contents yielded a pure growth of an Actinomyces species. Cholelith analysis revealed that they consisted of 100% bilirubin. Antibiotic treatment was stopped 4 weeks after surgery but UDCA was continued indefinitely. The cat remains clinically well with no recurrence of cholelithiasis 20 months after initial presentation. This is the first report of successful treatment and long-term follow-up of a cat with EHBO due to bilirubin cholelithiasis in association with PK deficiency-induced chronic haemolysis.


2018 ◽  
Vol 50 (2) ◽  
pp. 155-156
Author(s):  
M. Manno ◽  
C. Barbera ◽  
V.G. Mirante ◽  
L. Miglioli ◽  
T. Gabbani ◽  
...  

Author(s):  
Chaloemphon Boonmee ◽  
Ueamporn Summart ◽  
Apichat Tantraworasin ◽  
Jiraporn Khorana ◽  
Pachararin Meesoi ◽  
...  

Introduction: Most of the Cholangiocarcinoma (CCA) patients are commonly found in an advanced stage and often presents with Malignant Biliary Obstruction (MBO). Palliative treatment using biliary drainage plays a major role in the treatment modalities. However, only a few studies with small number of subjects have reported their long term outcomes. Aim: To compare the mortality rates of MBO patients in Endoscopic Ultrasound-guided Biliary Drainage (EUS-BD) era versus non-EUS-BD era. Materials and Methods: The present study was a retrospective cohort study which enrolled 132 MBO patients who had received palliative treatment between January 2014 to August 2020 at Thabo Crown Prince Hospital, Nong Khai, Thailand. The patients were treated either with EUS-BD (group l, n=30) or non-EUS-BD (group ll, n=94). Due to imbalance of follow-up time between two groups, the Overall Survival (OS) rates were compared using parametric survival analysis with restricted mean difference at 12 months follow-up, adjusted by other covariates, and presented in term of Kaplan-Meier curve, Hazard Ratio (HR) and 95% confidence interval. Results: Most of the patients (99.19%) were having CCA. The clinical characteristics between the two groups showed no significant difference, except the mean follow-up time that group II was shorter than group I (2.43 vs. 7.12 months; p<0.001). At 12 months after treatment, the OS rate of group I remained significantly higher than group II (mean difference=2.23; 95%CI: 0.54-3.92; p=0.010). The parametric-Cox proportional hazard model showed that the 1-year mortality of patients in group I were 63% less than those in group II, the parametric model between two groups showed statistical significance with p-value=0.043. Conclusion: From present study it can be concluded that EUS-BD in MBO patients achieves lower mortality rate at one year follow-up. For conclusive findings of the benefit of EUS-BD, a prospective long term study with larger numbers of subjects should be performed.


2019 ◽  
Vol 42 ◽  
Author(s):  
John P. A. Ioannidis

AbstractNeurobiology-based interventions for mental diseases and searches for useful biomarkers of treatment response have largely failed. Clinical trials should assess interventions related to environmental and social stressors, with long-term follow-up; social rather than biological endpoints; personalized outcomes; and suitable cluster, adaptive, and n-of-1 designs. Labor, education, financial, and other social/political decisions should be evaluated for their impacts on mental disease.


Sign in / Sign up

Export Citation Format

Share Document